Relapsed/refractory MCL patients treated with Zanubrutinib
ABSTRACT 06/2020
For more information about this resource, please submit a medical information request.
Outcomes of relapsed/refractory MCL patients treated with Zanubrutinib monotherapy in the second line and in later lines: A pooled analysis from 2 studies
Rating
